An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy
Cancers（2024）
Key words
stage III,resectable,locally advanced,NSCLC,lung cancer,immunotherapy,perioperative,neoadjuvant,immune checkpoint inhibitors,ICI
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined